Clinical Trials Browser

Phase 3 × hetrombopag × 1 year × Clear all

NCT03976882 2025-05-16

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.

Phase 3 Completed

Classical hematology

Chemotherapy-Induced Thrombocytopenia